Upload
amalie
View
22
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Veerle Piessens General Practitioner – Ghent - Belgium Assistant Dpt . General Practice and Primary HealthCare , Ghent University. Do good , and fear no one ? GP and Cancer Screening , an ethical perspective. Imagine a health problem …. Imagine a serious health problem. - PowerPoint PPT Presentation
Citation preview
Do good, and fear no one?GP and Cancer Screening, an ethical perspective
Veerle Piessens General Practitioner – Ghent- BelgiumAssistant Dpt. General Practice and Primary
HealthCare, Ghent University
Imagine a health problem…
Imagine a serious health problem Every year (in the UK)
• > 2000 deaths• 25000 people with serious morbidity
Preventive intervention Avoids 99%
Intervention – 99% effective?Stop people from driving cars and motorized vehicles.
Background
Belgium: 1 screening programme: breastcancer High opportunsitic screening cervical
cancer and prostate cancer. Almost no colorectal cancer screening
Fee for service Very little regulation on content of
the job
Background
Positive attitude towards cancer screening
In general In medical school
4 basic ethical priciples
Do good Do not harm Autonomy Justice
Do good“The principle of beneficence refers to a statement of moral obligation to act for the benefit of others.”Beauchamp & Childress, Principles of Biomedical Ethics.
What is good?
What are ‘the benefits’? Do we have evidence? How do we communicate the
benefits?
Benefits of cancerscreening? Early detection of cancer? Disease-related mortality-reduction. Less morbidity < less agressive
therapy
… and the patient?
Patients view on ‘benefits’? Mortality Reduction
Strongly overestimated (x10) More cure/less agressive therapy Reassurance of negative tests 1
Prevention of cancer 2
Silverman E, Woloshin S, Schwartz LM, Byram SJ, Welch HG, Fischhoff B. Women'sviews on breast cancer risk and screening mammography: a qualitative interviewstudy. Med Decis Making. 2001 May-Jun;21(3):231-40.
1. Silverman E e.a. Women's views on breast cancer risk and screening mammography: a qualitative interview study. Med Decis Making. 2001 May-Jun;21(3):231-40.
2. Domenighetti G e.a. Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol. 2003 Oct;32(5):816-21.
Patients expectations of screening… … are not similar. … are not always realistic. … some can impossibly be met
Evidence of benefit?
Screening is an intervention with healthy people.
Strong evidence is needed. Randomized Clinical Trials (RCT)
Do we have evidence of benefit? Screening cervical cancer started
without evidence. Prostate cancer screening started
without evidence. Good quality RCT’s for colorectal
cancer screening with FOBT. Plenty of RCT’s for breast cancer
screening with mammography, but …
Evidence for breast cancer screening? Questions about quality of the trials Best quality no evidence of benefit. Mediocre quality evidence of
mortality reduction
How much benefit?
Relative Risk Reduction
Enough information?
RRR
Breast Cancer 1 15-20%Cervical Cancer 2 60%Colorectal Cancer 3 15-20%Prostate Cancer 4 20%
1. Gøtzsche PC, e.a. Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD001877. DOI: 10.1002/14651858.CD001877.pub4
2. Raffle AE e.a. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ. 2003 Apr 26;326(7395):901.
3. Hewitson P e.a. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD001216. DOI: 10.1002/14651858.CD001216.pub2
4. Schröder FH e.a. ERSPC Investigators. Screening and prostate-cancermortality in a randomized European study. N Engl J Med. 2009 Mar 26;360(13):1320-8. Epub 2009 Mar 18. PubMed PMID: 19297566.
Relative Risk Reduction
What does it mean in ‘real value’ ‘Natural frequencies’
Prostate Cancer Screening 10000 men
▪ 36 die without screening▪ 29 die with screening
7 of 10000 men profit from screening.
RRR Mortality WITHOUT screening
MortalityWITHscreening
Who profits?
Breast Cancer 15-20% 4/1000 3/1000 1/1000
Cervical Cancer
60% 25/10000 15/10000 1/1000
Colorectal Cancer
15-20% 100/10000 85/10000 1-2/1000
Prostate Cancer
20% 36/10000 29/10000 <1/1000
DO GOOD
What are “the goods” we are aiming for?
Do our patients have the same expectations?
Is there reliable evidence? What is the magnitude of the
benefit?
Do not harm“The principle of nonmaleficence imposes an obligation not to inflict harm on others.” Beauchamp & Childress, Principles of Biomedical Ethics.
DO NOT HARM
Fear appeal and other emotional recruitment strategies.
False positive results False negative results Overdiagnose en overtreatment
Emotional recruitment strategies:
Woloshin S, Schwartz LM. Numbers needed to decide. J Natl Cancer Inst. 2009Sep 2;101(17):1163-5. Epub 2009 Aug 11. PubMed PMID: 19671771.
FROG PERSPECTIVE
Put it in at top-10:Cervical cancer is one of the top-10 cancers in women between 15 and 45
Put it in a worldwide perspective:Wordlwide there are every year 500 000 cases of cervical cancer.
Put it in a time perspectiveIn Europe every 18 minutes a woman dies of cervical cancer
In Belgium each year 1/10000 woman 600 are diagnosed with cervical cancer.
False Positive Results
Fear, anxiety, other psychological side-effects. 3 years after the test
Extra medical procedures Sometimes dangerous
Risk of FP result: Mammo: ¼ - ½ Colorectal: 1 person ‘saved’ – 125 pp
with FP
(False) Negative Results
Delay in diagnosis and treament Loss of confidence in own clinical
judgement and in health care system.
Getz L, Brodersen J. Informed participation in cancer screening: the facts arechanging, and GPs are going to feel it. Scand J Prim Health Care. 2010 Mar;28(1):1-3.
Overdiagnosis
Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010 May5;102(9):605-13. Epub 2010 Apr 22. Review.
The balance – 1000 women
Respect patients autonomyDit 3e ethische basisprincipe stelt dat mensen zelf vrij, zonder dwang, beslissingen mogen nemen aangaande hun gezondheid en medische interventies, voor zover deze beslissingen geen anderen schaden.
Respect patients autonomyBeauchamp & Childress, Principles of Biomedical Ethics.
Do we respect our patients autonomy? What is our role as GP
Are all conditions fullfilled? Are our patiens aware of the
existence of cancer screening? Do patients have correct knowledge?
About cancer? About benefits? About harms?
Patients screening – behavior Overscreening Underscreening
What is our role as GP
Information: Lower socio-economic classes/minority-
groups Worried-well
Population – individual Benefit exceeds harm on population-level. Individual level: value of benefits, value of
harm. Threats for autonomy
Targets
Balance GP’s have the opportunity – nobody else has. But…
Do GP’s have balanced information? Is this our priority? Won’t it distract us from the questions our patients
consult for? But…
If we don’t make a choice, choices will be made for us.
Lobby for more balanced information by other channels
What to do when…
… when principles seem to be conflicting?
… when patients have not enough mental capabalities to decide?
… when patients prefer not to decide and leave it to you?
Justice A group of norms for fairly distributing benefits, risks and costs
Justice Is there a problem?
Cancer screening is often free. Available for everybody.
Important socio-economic health disparities, also for cancer: Higher cancermortality Less ‘state of the art’ follow-up Less participation in cancer screening Benefits of cancer screening are not fairly distributed
Justice
Access to healthcare? Not for everybody Screening is free, but follow-up isn’t
financial barrier. Underscreening in lower SE classes
Less informed Long term perspective No priority in daily struggle for life
Justice
Overscreening in higher SE classes No extra benefit More harm Using publicly funded resources
Justice as ‘guide’ for the GP Everybody has a GP.
We see those people who are not reached by PH campaigns.
We see those who are overscreened Opportunity:
to inform them about screening. to stand by our patients
Unequal treatment of unequal people more intensive for those who need
more
Access to healthcare
GP: high accessibility Cherish it, promote it, expand it
Advocate for our patients
conclusion
4 principles
Broader perspective: Tunnel panoramic
Used in a comprehensive way Justice – autonomy
Motive to fullfill our role Harm – Good
Basis for the content
Thank you very much!